← Leaderboards
Ellen Monica Beauchamp
Harvard Medical School
$54,934
Attributed
$54,934
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.2K · FY2018–19$50K$37.5K$25K$12.5K$0
'18
'19
Funding mix
By agency
NIH$54,934 · 1
By mechanism
F31$54,934 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Stephen Buratowski$21,798,771
- Andrew Bruce Lassar$15,065,323
- Karen L Adelman$3,834,499
- Michael Chorev$1,744,295
- Azeddine Atfi$8,523,232
Others in their field
Other Emerging Leaders on “Acute Myelocytic Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Leonard Freedman · Leidos Biomedical Research, Inc.$12,430,568
- Crystal Mackall · Children'S Hosp Of Philadelphia$6,450,142
- Christopher A Miller · Washington University$5,424,298
- Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,329,699
- Kelly Diringer Getz · University Of Pennsylvania$4,068,250
Research focus
Acute Myelocytic LeukemiaBindingBinding ProteinsBiologicalBloodCell Cycle RegulationCell DivisionCellsClonal EvolutionClonal ExpansionComplexDna BindingDnmt3aDysmyelopoietic SyndromesEpigenetic ProcessExome SequencingFutureGene ExpressionGenesGenetic TranscriptionHematologic NeoplasmsHematopoiesisHematopoieticHematopoietic Neoplasms